Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Amgen Inc AMGN

Healthcare Biotechnology
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL... see more

Recent & Breaking News (NDAQ:AMGN)

AMGN FINAL DEADLINE MAY 12: ROSEN, A TOP RANKED LAW FIRM, Encourages Amgen Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - AMGN

PR Newswire May 8, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN

Newsfile May 8, 2023

NEW DATA FROM AMGEN'S PROLIA® (DENOSUMAB) DEMONSTRATES SIGNIFICANT REDUCTION IN OSTEOPOROTIC FRACTURE RISK COMPARED TO ALENDRONATE

PR Newswire May 8, 2023

AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit

PR Newswire May 8, 2023

AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)

PR Newswire May 8, 2023

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Amgen Investors of a Lead Plaintiff Deadline of May 12, 2023

PR Newswire May 8, 2023

Amgen Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Amgen Inc. and Encourages Investors to Contact the Firm

Newsfile May 7, 2023

Amgen Shareholder Notice

Newsfile May 7, 2023

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action - AMGN

Newsfile May 6, 2023

AMGEN SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amgen To Contact Him Directly To Discuss Their Options

PR Newswire May 6, 2023

Amgen Shareholder Action Reminder

Newsfile May 5, 2023

AMGN SHAREHOLDER ALERT: Jakubowitz Law Reminds Amgen Shareholders of a Lead Plaintiff Deadline of May 12, 2023

PR Newswire May 5, 2023

AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit

PR Newswire May 4, 2023

Amgen Inc. Securities Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Amgen Inc. That A Securities Fraud Class Action Lawsuit Has Been Filed on Their Behalf

Newsfile May 4, 2023

AMGN LAWSUIT ALERT: Levi & Korsinsky Notifies Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire May 4, 2023

AMGEN TO PRESENT AT THE 2023 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

PR Newswire May 3, 2023

AMGN NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action - AMGN

Newsfile May 3, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Amgen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2023 - (NASDAQ: AMGN)

PR Newswire May 3, 2023

AMGEN INC. (AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (AMGN)

Newsfile May 3, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN

PR Newswire May 3, 2023